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 1 
Abstract 
Preeclampsia is a pregnancy-specific condition affecting 2-7% of women and a leading cause 
of perinatal and maternal morbidity and mortality; it may also predispose the mother and fetus 
to increased risks of adult cardiovascular disease. The selenoprotein glutathione peroxidases 
(GPxs) have critical roles in regulating antioxidant status.  30 
Objectives, study design and main outcome measures: Immunohistochemical 
measurements of GPx 1, GPx3 and GPx4 protein expression were performed on samples 
taken from three standardised sampling sites between the cord insertion and the periphery of 
the placenta from 12 normotensive, and 12 preeclamptic women to establish if their 
expression differed between sampling sites. Total GPx activities were also examined from the 35 
three sampling sites of these placentae.   
Results: There were highly significant reductions in overall immunohistochemical staining of 
all 3 GPxs in the preeclampsia compared to normotensive placentae (GPx1: P = 0.016; GPx3: 
P = 0.003; GPx4: P < 0.001). Furthermore, graded differences in expression between the 
standardised placental sampling sites were also found for GPx3 (higher in the inner region, P 40 
= 0.05) and GPx4 (higher in the periphery, P = 0.02) but not GPx1. Placental GPx enzyme 
activity was also significantly reduced in tissue from preeclamptic women as compared to 
normotensive women (P = 0.007; the difference was more pronounced nearest the cord 
insertion). 
Conclusions: We have shown highly significant reductions in expression of all three major 45 
classes of GPx in placentae from women with preeclampsia, and distribution gradients in 
activity, which may relate to the differential oxygenation of regions of the placenta.  
 
Keywords: Preeclampsia; hypertension; oxidative stress; glutathione peroxidase; placenta. 
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Abbreviations: Glutathione peroxidases: GPxs; Intrauterine growth restriction: IUGR; 50 
intraclass correlation coefficient: ICC. 
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Introduction 
Preeclampsia is estimated to occur in 2-7% of all pregnancies and is a leading cause of 
maternal and perinatal mortality and morbidity in the Western world [1]; together with the 55 
other hypertensive disorders of pregnancy it is responsible for approximately 60,000 maternal 
deaths each year [2] and increases perinatal mortality five-fold  [3]. Preeclampsia is now 
commonly regarded as being a state of oxidative stress, thought to arise from a very early 
biochemical imbalance due to excessive free radical formation and/or inadequate antioxidant 
capacity (see: [4]). It is thought that excessive production of reactive oxygen species (ROS), 60 
resulting in oxidative stress secondary to reduced placental perfusion plays a critical role as a 
possible mediator of endothelial cell dysfunction [5], hypertension and thus clinical 
manifestations of preeclampsia [6]. Recent evidence has shown that the deleterious effects of 
pre-eclampsia in a woman and her baby extend beyond pregnancy into her later life, including 
increased risk of cardiovascular disease, diabetes and end stage renal disease [7-9]. 65 
 
The glutathione peroxidases (GPx) are antioxidants which provide protection from oxidative 
damage by reducing lipid hydroperoxides to their corresponding unreactive alcohols and 
reducing free hydrogen peroxide to water. This limits adverse effects on the endothelium [10] 
from reactive free radicals and cytotoxic agents [11].  Various forms of GPx are found in 70 
vertebrates: the cellular and cytosolic GPx (GPx1), the cytosolic gastrointestinal GPx (GPx2), 
the extracellular plasma GPx (GPx3) and the phospholipid hydroperoxide GPx (GPx4) [12].  
The regulation of this type of enzyme alters in different situations depending on oxygen 
tension, cell differentiation and tissue maturation [13] . The trace element selenium is an 
essential component of the antioxidant selenoproteins, including the GPxs. Our group and 75 
others have shown decreases in maternal and fetal serum selenium concentrations in 
preeclamptic patients compared to normotensive controls and have also reported significant 
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parallel reductions in maternal and fetal plasma and placental GPx activities in preeclamptic 
patients [14-17].   
 80 
Although the placenta is a discrete organ, its complex structure results in heterogeneous 
function in different areas.  The degree of vascularisation differs across the placenta resulting 
in differences of oxygen availability in these locations [18] with most gaseous exchange 
occurring at the periphery where blood flow is greatest.  There are known regional variations 
in tissue sensitivity to polypeptides [19]; cytokine protein concentrations can vary up to 3-fold 85 
across different sampling sites of the placenta [20]  and expression of hypoxia-related genes, 
such as vascular endothelial growth factor, is lower near the basal plate close to the cord 
insertion site and higher at the peripheral chorionic plate [21].  Although the distribution of 
selenium within the placenta has not been examined, other elements such as iron and calcium, 
have been reported to be differentially distributed across the placental disc [22]. A single 90 
study of GPx mitochondrial activity found this to be 41 per cent lower in the periphery 
compared to the pre-insertion region [23].   In an earlier paper [17] we reported that sampling 
site did not affect expression of GPx, but we did identify an apparent trend, and only 
examined 15 placentae (7 preeclampsia and 8 normotensive). We are not aware of any other 
studies examining GPx placental protein expression from different sampling sites of the 95 
placenta.  
 
We hypothesised that GPx1, GPx3 and GPx4 expression, identified by 
immunohistochemistry, would alter in different areas of the placenta, as well as being reduced 
in preeclamptic pregnancy. We have therefore conducted a cross-sectional study to explore 100 
these factors, comparing placentae from normotensive and preeclamptic pregnancies. 
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Methods 
Subjects: The study population consisted of White European women who had either a 105 
normotensive or preeclamptic pregnancy (Table 1).  The investigations were approved by the 
Nottingham Hospital Ethics Committee and written, informed consent was obtained from 
each participant.  Cases were defined on admission with a clinical diagnosis of preeclampsia, 
defined as a systolic blood pressure of 140 mm Hg or more and diastolic pressure (Korotkoff 
V) of 90 mm Hg  or more on 2 occasions after 20 weeks gestation in a previously 110 
normotensive woman and proteinuria ≥300 mg/L, ≥500 mg/day or ≥2+ on dipstick analysis of 
midstream urine (MSU) if 24-hour collection result was not available [24].  Medical and 
obstetric histories, including delivery data, were obtained for each woman. The birthweight 
centile for each baby was computed, correcting for gestation age, sex, maternal parity and 
body mass index (BMI) [25].   115 
 
Sample collection: Twelve placentae from preeclamptic women, and 12 controls were studied.  
Data from 7 preeclampsia and 8 normotensive placentae were reported in [17]. Two full depth 
placental tissue samples were collected from three standardised locations between cord 
insertion and placental border (1 cm from the cord insertion, 1 cm from the periphery, and 120 
midway between the two), avoiding placental infarcts.  The placental samples were taken 
within 10 minutes of delivery, membranes removed and tissue washed in ice cold 1x PBS to 
remove maternal blood contamination. One set was snap frozen in liquid nitrogen and stored 
at -80oC for GPx enzyme activity and the other formalin fixed and wax-embedded for 
immunohistochemical analysis. 125 
 
Histological analysis: Serial sections of 5 μm were cut in the same orientation from paraffin-
embedded tissue blocks (Sledge Microtome, Anglia Scientific, Norwich, UK) and mounted 
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onto Superfrost plus glass microscope slides (Menzel-Glaser, Braunschweig, Germany). 
Before use, sections were dewaxed by immersion in xylene followed by rehydration in 130 
descending concentrations of alcohol (3 min each). 
 
Immunohistochemistry: Immunohistochemical staining was performed using the Dako 
Envision™ visualization system (Dako, Ely, UK).  All GPx antibodies were purchased from 
Autogen Bioclear; Table 2 provides further details on antibody dilutions and positive controls, 135 
which were optimised by performing a dilution series for each antibody.  Antibodies to 
cytokeratin (CK-7) and CD-68 (Santa Cruz Biotechnology, Calne, UK) were used to confirm 
positive GPx staining in cytotrophoblast and Hofbauer cells respectively [17]. The heat 
induced epitope retrieval was achieved by heating in a citrate buffer (pH 6.0) using a 
microwave oven for 15 minutes. A negative control was performed for each test section by 140 
omitting incubation with the primary antibody. A positive control for each antibody was used 
to verify specificity:  human thymus (GPx1), prostate (GPx3), tongue (GPx4) as 
recommended by Autogen Bioclear; both positive and negative controls were completed on 
serial sections. Sections were dehydrated and cleaned in ascending concentrations of alcohol 
and xylene before coverslips were mounted (DPX mountant, BDH). 145 
 
Quantification was performed at x400 magnification (Nikon Eclipse II microscope) using a 
previously described method [26]. This is a grid-based method which allows unbiased 
counting of positively stained cells/areas and requires no normalisation. NIS Elements F 2.20 
software (Laboratory Imaging Ltd) was used for quantification.  All analysis was performed 150 
blinded as to group by the same assessor (HDM) and independently double counted by a 
trained second assessor (PJW); a reference slide was used throughout to check for 
consistency. The intraclass correlation coefficient (ICC) (ratio of between-groups variance of 
 7 
the total variance) was used to assess agreement between judges [27, 28]. The ICCs for each 
antibody were r = 0.996 (P < 0.001) for GPx1; r = 0998 (P < 0.001) for GPx3 and r = 0.995 155 
(P < 0.001) for GPx4.   
 
GPx activity assay: Placental GPx activity was determined by a modified method of Paglia 
and Valentine  [29]. Placental tissue (100 mg) was extracted using RIPA buffer (1 x PBS (pH 
7.4), 0.1 % SDS, 1 % Igepal CA-630 (Sigma-Aldrich, Poole, UK) and 0.5% sodium 160 
deoxycholate) and protein concentrations were determined by the Lowry protein assay. 
Activity was measured spectrophotometrically in triplicate by coupling the oxidation of 
glutathione and nicotinamide adenine dinucleotide phosphate (NADPH) using glutathione 
reductase, described in detail previously [17]. GPx activity was standardised against protein 
concentrations and expressed as mmol/min/mg protein; the inter- and intra-assay variations 165 
were < 5%.  
 
Statistical analysis: All tests were performed using SPSS for Windows version 16.0.  
Summary data are presented as means ± SD or median (interquartile range) as appropriate for 
their distribution.  Between-group comparisons were made using repeated measures ANOVA 170 
/Kruskal-Wallis tests or 2-tailed student’s t test/Mann-Whitney U-tests depending on the 
distribution.  Kendall’s  tests were used to test for differential staining intensities between 
placental sampling sites. The null hypothesis was rejected where P < 0.05.   
 8 
Results 175 
Subjects: Table 1 describes the demographic, obstetric and pregnancy data of the 24 women 
(12 normotensive, 12 preeclampsia) who participated in the study.  All women conceived 
naturally and carried singleton pregnancies.  The normotensive group gave birth without 
developing hypertension or proteinuria, to infants weighing > 2500 g, delivered 37 weeks or 
later.  The systolic and diastolic blood pressure levels were, by definition, significantly raised 180 
in preeclampsia compared to normal pregnancy (P < 0.0001).  Overall, the preeclamptic 
women all had moderate to severe disease and had lower gestational ages at delivery than the 
control group (P < 0.05) (Table 1). No preeclamptic woman had HELLP (Hemolysis Elevated 
Liver enzymes, and Low Platelet count). All neonates from both pregnancy groups survived.   
 185 
Immunohistochemistry:  As we have previously shown GPx 1, GPx3 and GPx4 were all 
positively expressed in both cytotrophoblast and Hofbauer cells [17] and the expression of all 
three enzymes was significantly reduced in preeclampsia (GPx1: P =0.016; GPx3: P =0.003; 
GPx4: P <0.001; Figures 1-3). The three samples were analysed in parallel to control for 
placental inhomogeneity with respect to potential gradient of oxygenation between the cord 190 
insertion and the peripheral border.  
 
Comparison of staining intensity across the placental sampling sites demonstrated differential 
localisation of the enzyme forms for GPx3 and GPx4, but not GPx1 (Figures 1- 3). Visual 
inspection indicated more intense staining for GPx3 towards the inner part of the placental 195 
disc, nearest the cord insertion (Figure 2; P = 0.05, Kendall’s ) in placentae from 
normotensive, but not preeclamptic, women. Five of the infants in the preeclamptic group had 
birthweight centiles below 10% (intrauterine growth restriction; IUGR) while 7 were above 
this value. The median (range) GPx3 staining near the cord insertion was 84 (65 – 97) units in 
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pre-eclamptic placentae associated with IUGR and 120 (70 – 151) units in preeclampsia 200 
without IUGR (P = 0.042).   
 
GPx4 positive staining, showed an opposite pattern, being significantly reduced in the inner 
part of the placental bed, with higher intensity at the outer edge (Fig 3; P = 0.02, Kendall’s ) 
only in the preeclamptic placentae. When GPx4 was examined in relation to IUGR in the 205 
preeclamptic group, the median (range) GPx staining in the outer edge was 75.7 (64.5 – 91.7) 
units in pre-eclamptic placentae associated with IUGR and 53.3 (22.5 – 80) units in 
preeclampsia without IUGR (P = 0.028). 
 
Placental GPx enzyme activity was also significantly reduced in tissues from preeclamptic 210 
women. The median placental GPx activity was 0.43 (0.19 – 0.56) nmol/min/mg in 
normotensive placentae, compared with 0.16 (0.10 – 0.28) nmol/min/mg in placentae from 
preeclamptic women (P = 0.007). This difference was most pronounced nearest the cord 
insertion (Table 3). 
 215 
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Discussion  
The main finding of our study is the differential changes in GPx expression and activity 
between preeclamptic and normotensive placentae. This is one of the first detailed studies to 220 
show the distribution of three of the main forms of GPx (GPx1, 3 and 4) in the human 
placenta. To ensure that the observed differences in GPx activity were not related to gestation 
age at delivery, we also compared these data with controls only for the preeclamptic women 
who delivered at ≥37 weeks’ gestation. All between-group differences remained statistically-
significant. 225 
 
These three forms have different locations and perform slightly different functions, though all 
GPxs reduce hydroperoxides via glutathione. GPx3 is the predominant GPx in the plasma, 
and not only scavenges hydrogen peroxide and metabolises peroxidised organic molecules but 
also maintains the bioavailability of vascular nitric oxide, thus decreasing systemic oxidative 230 
stress. GPxs in the cytotrophoblast are ideally located for release into both the maternal and 
fetal circulations; these cells are exposed to relatively high oxygen concentrations and thus 
may protect the cells from oxidative stress [30].   
 
Regulation of specific GPxs has been demonstrated at a number of levels; the effects of 235 
hypoxia on up-regulation of GPx3 expression are transcriptional whilst selenium and 
oxidative stress are believed to regulate GPx3 through both transcriptional and translational 
mechanisms [31]. Stability of mRNA for selenoproteins is controlled by nonsense-mediated 
decay [32, 33]  which in turn is controlled by selenium supply; the available selenium being 
prioritised for synthesis of particular selenoproteins [34].  Regulation of GPx3 remains mainly 240 
uncharacterised; in inflammatory conditions, oxidative stress upregulates GPx3 at the 
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transcriptional level [35] yet surprisingly, the response to a more oxidised state in cancer cells 
is down-regulation [35]. 
 
The differential distribution of GPx4 in preeclampsia and in relation to IUGR has not been 245 
previously reported. GPx4 has been implicated in the functional modulation of cellular 
metabolic pathways, or more specifically, silencing eicosanoid formation by suppressing the 
activity of 15-lipoxygenase [36]. Hence the lower levels of this enzyme in preeclampsia may 
be contributing to the increased production of 15-hydroxyeicosapentaoic acid (15-HETE) by 
the placental trophoblast [37].  At present the source of the lipid peroxides in preeclampsia is 250 
unknown, but it has been suggested that poorly perfused placental tissue may evoke a free 
radical cascade and increase in generalised lipid peroxidation [38].  By entering the maternal 
circulation, these lipid peroxides could affect the maternal endothelial cellular membranes by 
the increased production of ROS, thus contributing to the maternal vascular dysfunction [16].  
The defective placentation in preeclampsia could prevent the active placental transport of 255 
these lipid peroxides away from the fetus. We have previously reported [17] increased levels 
of thiobarbituric acid reactive substances (TBARS) in umbilical venous blood from cases with 
preeclampsia. The increased GPx4 expression in the periphery of the placenta could be due to 
this area having the highest density of terminal vasculature.  This area of the placenta is 
known to be more sensitive to a variety of vasoactive substances [19], and so this increase in 260 
GPx4 may be a compensatory increase. At present, there is little known about the mechanism 
of GPx4 activation and so we cannot speculate any further. 
 
The functional effect of such gradients cannot be determined at present. At least in the second 
trimester, both anatomical and Doppler studies have shown lower impedance to flow in the 265 
spiral arteries of the peri-insertion area of the placenta [39] where we identified the greatest 
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GPx3 expression. The reduced GPx3 expression in preeclamptic placentae might thus be of 
particular significance here and larger studies are required to fully investigate this. Studies of 
human placental samples in vitro suggested that enhanced villous maturation, syncytial knots 
and fibrin deposits, all features of preeclamptic placentae, were more frequent in samples 270 
from the outer edge under hypoxic conditions, and correlated with up-regulation of hypoxia-
related transcripts [21]. Hypoxia has been shown to up-regulate GPx3 expression almost 3-
fold in a renal cell line [40]; we are not aware of comparable studies of GPx4.  Our group has 
previously shown no differences in placental GPx1, 3 and 4 mRNA expression between 
pregnancy groups [17].  However, the reduction of GPx activity and protein expression in the 275 
preeclamptic placentae indicates a possible post-translational modification/mutation reducing 
the GPx antioxidant activity; this has been observed outside pregnancy [41]. 
 
This study also observed no differences in GPx1 expression between sampling sites; GPx1 is 
the major cellular/cytosolic form of the enzyme. The expression of GPxs has been shown to 280 
be hierarchical, dependent on the availability of selenium, with GPx1 ranked low among the 
GPxs and other selenoproteins [12]. It has also been suggested that GPx1 may be more 
important as a buffer or storage form of selenium than as a glutathione peroxide [42, 43].  We 
speculate that this may be a contributing factor relating to this lack of regulation of GPx1 
which requires further investigations. 285 
 
Due to the limitations of the activity assay in specificity for each GPx isoforms, we plan to 
measure GPx 1, GPx3 and GPx4 expression in the three placental locations using Western 
Blot analysis, which would enable further justification of the immunohistochemical data.  
Also, although the numbers of Caesarean sections were significantly higher in the pre-290 
eclamptic group compared to the normal pregnancies, all were performed in established 
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labour. We unfortunately did not record the duration of labour. It has been reported that 
labour increases maternal leukocyte GPx activity in normal pregnancies [44]. Therefore, it 
could be suggested that placentae from preeclamptic pregnancies may not have the same 
ability to respond to the ischemic hypoxic stress during labour that the normal pregnant 295 
placentae have, thus resulting in the reduction of both placental GPx activity and expression 
in preeclampsia observed in this study, but this requires further investigation. 
 
There are morphological differences between placentae from women with preeclampsia alone, 
IUGR alone and preeclampsia with IUGR [45]. The surface area of peripheral villi is 300 
relatively decreased in preeclampsia with IUGR and the trophoblast volume is decreased but 
its thickness increased, which would impair transport of gases and nutrients.  We observed a 
significantly lower placental GPx3 staining in preeclampsia with IUGR pregnancies but 
greater GPx4 staining.  Whether such differences are cause or consequence is at present 
entirely speculative and requires further investigation. 305 
 
In conclusion, we have shown distribution gradients in GPx expression and activity, which 
may relate to the differential oxygenation of regions of the placenta. As noted in the 
Introduction, there is increasing realisation that standardisation of placental sampling site is 
important, because both expression of various genes and vascular function differ across the 310 
placenta [18-21]. Our demonstration of significant gradients of GPx activity further supports 
the need for clear description of how placental sampling is standardised. 
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